The aim of the study was to investigate the pharmacokinetics of diazepam and the formation of one of its active metabolites, N-desmethyldiazepam, after a single i.v. dose, during repeated oral administration of H 199/18 or placebo in healthy subjects.

Study identifier:SH-QBE-0003

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

The aim of the study was to investigate the pharmacokinetics of diazepam and the formation of one of its active metabolites, N-desmethyldiazepam, after a single i.v. dose, during repeated oral administration of H 199/18 or placebo in healthy subjects.

Medical condition

gastrointestinal diseases

Phase

N/A

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria